Trexquant Investment LP - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 281 filers reported holding ROYALTY PHARMA PLC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.6%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$8,539,737
-39.4%
314,655
-31.3%
0.21%
-42.0%
Q2 2023$14,087,773
+1303.5%
458,288
+1545.0%
0.37%
+1217.9%
Q1 2023$1,003,760
-45.8%
27,859
-40.6%
0.03%
-47.2%
Q4 2022$1,853,172
-77.7%
46,892
-78.0%
0.05%
-86.4%
Q1 2022$8,316,000
+1053.4%
213,440
+1079.6%
0.39%
+768.9%
Q4 2021$721,000
+90.7%
18,095
+96.2%
0.04%
+40.6%
Q2 2021$378,000
-72.7%
9,223
-71.0%
0.03%
-74.8%
Q1 2021$1,386,00031,7670.13%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders